The purpose of this legislation is to improve access to non-opioid pain management medications for Medicare beneficiaries. It aims to address the growing concern over opioid addiction by promoting alternative pain relief options that do not involve opioids. Key provisions of the legislation include several important changes to Medicare Part D. Starting January 1, 2026, qualifying non-opioid pain management drugs will not be subject to deductibles, meaning patients won't have to pay out-of-pocket costs before their insurance kicks in.